These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2862396)

  • 1. Non-A, non-B hepatitis and heat-treated factor VIII concentrates.
    Preston FE; Hay CR; Dewar MS; Greaves M; Triger DR
    Lancet; 1985 Jul; 2(8448):213. PubMed ID: 2862396
    [No Abstract]   [Full Text] [Related]  

  • 2. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders: a preliminary report of an antigen/antibody system.
    Bamber M; Murray A; Kernoff PB; Thomas HC
    Med Lab Sci; 1981 Oct; 38(4):373-8. PubMed ID: 6799726
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hepatitis non-A, non-B following administration of factor VIII concentrates.
    Norkrans G; Widell A; Teger-Nilsson AC; Kjellman H; Frösner G; Iwarson S
    Vox Sang; 1981 Sep; 41(3):129-33. PubMed ID: 6800131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood product concentrates and chronic live disease.
    Preston FE; Triger DR; Underwood JC
    Lancet; 1982 Mar; 1(8271):565. PubMed ID: 6120418
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of hepatitis C virus infection in haemophiliacs.
    Lancet; 1990 Jun; 335(8703):1473-4. PubMed ID: 1972253
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate.
    Colombo M; Mannucci PM; Carnelli V; Savidge GF; Gazengel C; Schimpf K
    Lancet; 1985 Jul; 2(8445):1-4. PubMed ID: 2861454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.
    Fletcher ML; Trowell JM; Craske J; Pavier K; Rizza CR
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1754-7. PubMed ID: 6416577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group.
    Mannucci PM; Schimpf K; Abe T; Aledort LM; Anderle K; Brettler DB; Hilgartner MW; Kernoff PB; Kunschak M; McMillan CW
    Transfusion; 1992 Feb; 32(2):134-8. PubMed ID: 1311876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis.
    Skidmore SJ; Pasi KJ; Mawson SJ; Williams MD; Hill FG
    J Med Virol; 1990 Jan; 30(1):50-2. PubMed ID: 2106006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis and factor VIII concentrates.
    Kernoff PB
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):8-13. PubMed ID: 3133777
    [No Abstract]   [Full Text] [Related]  

  • 13. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
    Heimburger N; Karges HE; Weidmann E
    Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-A, non-B hepatitis after factor VIII concentrate treated by heating and chloroform.
    Mannucci PM; Colombo M; Rodeghiero F
    Lancet; 1985 Nov; 2(8462):1013. PubMed ID: 2865484
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII/von Willebrand factor replacement therapy. Problems and challenges.
    Aledort LM
    Ann N Y Acad Sci; 1987; 509():49-52. PubMed ID: 3122619
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease.
    Kreuz W; Klarmann D; Auerswald G; Auberger K; Gürtler L; Rabenau H; Doerr WD
    Lancet; 1993 Feb; 341(8842):446. PubMed ID: 8094219
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for existence of at least two types of factor-VIII-associated non-B transfusion hepatitis.
    Craske J; Spooner RJ; Vandervelde EM
    Lancet; 1978 Nov; 2(8098):1051-2. PubMed ID: 82066
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of haemophilia A with concentrated preparations of factor VIII.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Bibl Haematol; 1968; 29():1166. PubMed ID: 5303859
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs.
    Mannucci PM; Colombo M; Rizzetto M
    Blood; 1982 Sep; 60(3):655-8. PubMed ID: 6809075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-transfusion hepatitis and its sequelae in the treatment of hemophilia].
    Schimpf K
    Behring Inst Mitt; 1983 Aug; (73):111-7. PubMed ID: 6433878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.